Showing results (431-440 of 445) with videos related to

Sort By:
Pageof 45
Gene|August 6, 2013
Delivery and processing of exogenous double-stranded DNA in mouse CD34+ hematopoietic progenitor cells and their cell cycle changes upon combined treatment with cyclophosphamide and double-stranded DNAEvgenia V Dolgova, Yaroslav R Efremov, Konstantin E Orishchenko, et al.
International Journal of Molecular Sciences|December 28, 2019
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor TherapyTatyana M Khomenko, Alexandra L Zakharenko, Arina A Chepanova, et al.
Gene|January 10, 2012
"Delayed death" phenomenon: a synergistic action of cyclophosphamide and exogenous DNAEvgenia V Dolgova, Anastasia S Proskurina, Valeriy P Nikolin, et al.
Vavilovskii Zhurnal Genetiki I Selektsii|March 4, 2021
[Characteristic of the active substance of the Saccharomyces cerevisiae preparation having radioprotective properties]G S Ritter, V P Nikolin, N A Popova, et al.
International Journal of Molecular Sciences|March 11, 2023
Impact of Double-Stranded RNA Internalization on Hematopoietic Progenitors and Krebs-2 Cells and MechanismGenrikh S Ritter, Anastasia S Proskurina, Maria I Meschaninova, et al.
Anticancer Research|July 7, 2021
Experimental Comparison of the In Vivo Efficacy of Two Novel Anticancer TherapiesVera S Ruzanova, Anastasia S Proskurina, Genrikh S Ritter, et al.
International Journal of Radiation Biology|July 14, 2020
Characterization of biological peculiarities of the radioprotective activity of double-stranded RNA isolated from Saccharomyces сerevisiaeGenrikh S Ritter, Valeriy P Nikolin, Nelly A Popova, et al.
Oncotarget|December 30, 2016
Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cellsEkaterina A Potter, Evgenia V Dolgova, Anastasia S Proskurina, et al.
Beilstein Journal of Organic Chemistry|September 28, 2012
Triterpenoid saponins from the roots of Acanthophyllum gypsophiloides RegelElena A Khatuntseva, Vladimir M Men'shov, Alexander S Shashkov, et al.
BMC Cancer|April 18, 2015
Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancerAnastasia S Proskurina, Tatiana S Gvozdeva, Ekaterina A Alyamkina, et al.
Pageof 45